In addition, silencing of pyruvate kinase isoenzyme M2 enhanced the efficacy of docetaxel and cisplatin (an alkylating agent) in human KRAS mutant lung cancer xenograft models [154,155]. The gene discussed is KRAS; the disease is lung carcinoma.